Brief Report: Airways Abnormalities and Rheumatoid Arthritis-related Autoantibodies in Subjects Without Arthritis: Early Injury or Initiating Site of Autoimmunity?
Overview
Authors
Affiliations
Objective: To evaluate the presence of pulmonary abnormalities in rheumatoid arthritis (RA)-related autoantibody-positive subjects without inflammatory arthritis.
Methods: Forty-two subjects who did not have inflammatory arthritis but were positive for anti-cyclic citrullinated peptide antibodies and/or ≥2 rheumatoid factor isotypes (a profile that is 96% specific for RA), 15 autoantibody-negative controls, and 12 patients with established seropositive early RA (<1-year duration) underwent spirometry and high-resolution computed tomography (HRCT) lung imaging.
Results: The median age of autoantibody-positive subjects was 54 years, 52% were female, and 38% were ever-smokers; these characteristics were not significantly different from those of autoantibody-negative control subjects. No autoantibody-positive subject had inflammatory arthritis based on joint examination. HRCT revealed that 76% of autoantibody-positive subjects had airways abnormalities including bronchial wall thickening, bronchiectasis, centrilobular opacities, and air trapping, compared with 33% of autoantibody-negative controls (P = 0.005). The prevalence and type of lung abnormalities among autoantibody-positive subjects were similar to those among patients with early RA. In 2 autoantibody-positive subjects with airways disease, inflammatory arthritis classifiable as articular RA developed ∼13 months after the lung evaluation.
Conclusion: Airways abnormalities that are consistent with inflammation are common in autoantibody-positive subjects without inflammatory arthritis and are similar to airways abnormalities seen in patients with early RA. These findings suggest that the lung may be an early site of autoimmune-related injury and potentially a site of generation of RA-related autoimmunity. Further studies are needed to define the mechanistic role of lung inflammation in the development of RA.
Thoracic manifestations of rheumatic disease: a radiologist's view.
De Clercq A, Jans L, Gosselin R, Delrue L, Vereecke E, Parkar A Ther Adv Musculoskelet Dis. 2024; 16:1759720X241293943.
PMID: 39620048 PMC: 11605741. DOI: 10.1177/1759720X241293943.
Airways Abnormalities in a Prospective Cohort of Patients With Rheumatoid Arthritis.
Matson S, Choi J, Rorah D, Khan S, Trofimoff A, Kim T Chest. 2024; 167(2):495-506.
PMID: 39343293 PMC: 11867896. DOI: 10.1016/j.chest.2024.09.006.
Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis.
Holers V, Demoruelle K, Buckner J, James E, Firestein G, Robinson W Nat Rev Rheumatol. 2024; 20(10):601-613.
PMID: 39251771 DOI: 10.1038/s41584-024-01154-0.
Arnaiz-Villena A, Juarez I, Vaquero-Yuste C, Lledo T, Martin-Villa J, Suarez-Trujillo F Biomedicines. 2024; 12(8).
PMID: 39200390 PMC: 11352054. DOI: 10.3390/biomedicines12081928.
Exploring the Role of the Microbiome in Rheumatoid Arthritis-A Critical Review.
Ermencheva P, Kotov G, Shumnalieva R, Velikova T, Monov S Microorganisms. 2024; 12(7).
PMID: 39065155 PMC: 11278530. DOI: 10.3390/microorganisms12071387.